InvestorsHub Logo
Followers 1
Posts 347
Boards Moderated 0
Alias Born 12/09/2016

Re: fbg0316 post# 16434

Thursday, 03/23/2017 5:37:52 PM

Thursday, March 23, 2017 5:37:52 PM

Post# of 108192
Fbg, i found this on the ema website under FAQ's:


"In general, the Agency will issue an opinion on its evaluation within 210 'active' days. However, the clock may be stopped during the procedure to allow companies to answer questions posed by the Agency's Committees. This leads to the actual evaluation time being longer."

"The European Commission follows the opinion of the Agency in almost all cases. It takes around two months (60 days) for the European Commission to approve a medicine after the Agency has given a positive opinion."

Also, i found this below under the FAQ "How can i keep up to date with the agency's opinions" for those that may want to subscribe. i didnt have time to look any further into it.

"After every meeting of the main human and veterinary committee meetings, the Agency issues a news release with highlights of the meeting. To stay up to date with the latest news, features and publications from the Agency, you can subscribe to our RSS feeds.

The Agency also publishes a monthly newsletter called 'human medicines highlights'. This newsletter provides key information on the Agency's recent activity on human medicines."

hovacre, i apologize if i seemed negative in actuality i am extremely excited that we could have an approved product in EU in less than a year. After being invested for 4 years its exciting that we could be treating someone battling cancer in as little as.....nobody has answered my question yet?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News